Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (3880)	7/21/2001 5:28:56 PM
From: Mike M	Read Replies (1) \| Respond to of 5582

This company has NEVER had a legitimately profitable year due to the sale of PRODUCTS and I doubt it ever will. ...and they just got rid of the reason for never having had a profitable year. All gum is doing is focusing on that part of the business that works. I realize that doesn't make sense to you but that is no one else's problem. GUMM's gum expertise will now be working for Wrigley and by virtue of their capital resources I suspect Kehoe will be very successful in the functional gum business. GUMM should even prosper from that for the next few years. At worst it would be a break even since shared revenues cost them nothing. The company has managed on a shoe string in the past. Now they find themselves with $30M in cash, no debt, one profitable product on the market an a jv nearing launch (which their only remaining financial obligation is to share in the profits). Yeah, Hank, doubt away about profitability.